Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.
SLAMF9 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | Q96A28 |
|---|---|
| Clone Names | 100406144 |
| Gene ID | 89886 |
|---|---|
| Other Names | SLAM family member 9, CD2 family member 10, CD2F-10, CD84 homolog 1, CD84-H1, SLAMF9, CD2F10 |
| Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Name | SLAMF9 |
|---|---|
| Synonyms | CD2F10 |
| Function | May play a role in the immune response. |
| Cellular Location | Membrane; Single-pass type I membrane protein. |
| Tissue Location | Expression is predominantly restricted in hematopoietic tissues. Expressed in heart, spleen, liver, intestine, muscle and testis. Expressed in immune cells, including monocytes, dendritic, B- and T-cells. No expression was seen in peripheral blood leukocytes. Expressed in the leukocyte cell line THP-1 |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
SLAMF9 is a member of the signaling lymphocyticactivation molecule family. The encoded protein is a cell surfacemolecule that consists of two extracellular immunoglobulin domains,a transmembrane domain and a short cytoplasmic tail that lacks thesignal transduction motifs found in other family members.
References
Calpe, S., et al. Adv. Immunol. 97, 177-250 (2008) :Fraser, C.C., et al. Immunogenetics 53 (10-11), 843-850 (2002) :Fennelly, J.A., et al. Immunogenetics 53(7):599-602(2001)Zhang, W., et al. Clin. Cancer Res. 7 (3 SUPPL), 822S-829S (2001) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.
Ordering Information
Other Products
Shipping Information
